The excessive activation of the JNK pathway is closely associated with metabolic abnormalities such as obesity and insulin resistance.[29,30] Specifically, JNK can inhibit insulin signal transduction by phosphorylating signaling molecules like insulin receptor substrate-1, exacerbating insulin resistance. The gene discussed is INS; the disease is obesity disorder.